Robert Uger

Insider Reports History

Entity
Individual
Location
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada
Signature
/s/ James Parsons, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Uger:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Trillium Therapeutics Inc. Chief Scientific Officer Stock Option (Right to Buy) 0 Nov 17, 2021 Direct

Insider Reports Filed by Robert Uger

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TRIL Trillium Therapeutics Inc. Nov 17, 2021 6 $0 4 Nov 19, 2021 Chief Scientific Officer
TRIL Trillium Therapeutics Inc. Jul 7, 2021 3 -$31.7K 4 Jul 9, 2021 Chief Scientific Officer
TRIL Trillium Therapeutics Inc. Jun 7, 2021 3 -$29K 4 Jun 9, 2021 Chief Scientific Officer
TRIL Trillium Therapeutics Inc. May 7, 2021 3 -$32.8K 4 May 11, 2021 Chief Scientific Officer